Chemomab Therapeutics
CMMB----
Forecast & Rating2 analysts currently cover Chemomab Therapeutics, of which 1 give a positive rating. The average price target is $5.00, about 267.6% upside from the current price of $1.36. Coverage is limited, so the data is for reference only. Data as of Jul 13, 2026; this does not constitute investment advice.
Jul 13, 2026Price forecast
$5.00267.65%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 19, 2026
Forecast met0.0%
Stock price$1.36
Average forecast price$17.5
Highest forecast price$25
Lowest forecast price$10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.